Feb 5, 2019
JP Milon is CEO of Paris-based Quantum Genomics, a company developing a treatment for patients with hypertension that is resistant to currently available medications. Over-represented in populations with resistant hypertension, minorities often suffer severe complications as a result of having perpetual high...